Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Adds Cardiovascular Drug Discovery Product

NEW YORK, May 15 – Gene Logic announced on Tuesday the launch of its Cardiovascular DataSuite as an extension product of its GeneExpress Suite. 

The cardiovascular package will include access to GeneExpress’ data management and analysis software platform. Subscribers to the new product will receive regular updates to the cardiovascular content and bioinformatics tools, according to the company.

The Cardiovascular DataSuite, aimed at pharmaceutical and biotechnology drug discovery and development customers, includes normal and diseased human cardiac and vascular tissues from a broad selection of individuals, races, medication regimens, lifestyles, and disease stages, the company reports.

The product also includes disease animal model systems related to cardiovascular indications to allow non-human and human disease model comparison. According to the Gaithersburg, Maryland-based, company, the new product will assist researchers in identifying potential new drug targets and surrogate markers for diagnosis, progression, and prognosis of cardiovascular diseases. 

“The Cardiovascular DataSuite is an extension of our mission to provide value-added gene expression information solutions that directly address the critical research and development needs of the pharmaceutical and biotechnology communities,” Gene Logic senior vice president for marketing and sales David S. Murray said in a statement.

 

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.